124 related articles for article (PubMed ID: 38443283)
21. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
22. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
23. Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China.
Zhang H; Tang X; Hu D; Li G; Song G
Front Public Health; 2022; 10():1026751. PubMed ID: 36589938
[TBL] [Abstract][Full Text] [Related]
24. Association between metabolic phenotype and urinary albumin-creatinine ratio in Chinese community adults: A cross-sectional study.
Zhang Y; Li B; Liu Y; Gao W; Chen K; Wang A; Tang X; Yan L; Luo Z; Qin G; Chen L; Wan Q; Gao Z; Wang W; Ning G; Mu Y
J Diabetes; 2022 Aug; 14(8):541-550. PubMed ID: 36040203
[TBL] [Abstract][Full Text] [Related]
25. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
27. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).
Vusirikala A; Thomas T; Bhala N; Tahrani AA; Thomas GN; Nirantharakumar K
BMC Endocr Disord; 2020 Jun; 20(1):96. PubMed ID: 32605642
[TBL] [Abstract][Full Text] [Related]
28. Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study.
Najafi F; Pasdar Y; Nazar MM; Darbandi M
BMC Endocr Disord; 2024 Jun; 24(1):96. PubMed ID: 38918729
[TBL] [Abstract][Full Text] [Related]
29. Risk of diabetes according to the metabolic health status and degree of obesity.
Janghorbani M; Salamat MR; Amini M; Aminorroaya A
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S439-S444. PubMed ID: 28404516
[TBL] [Abstract][Full Text] [Related]
30. Combined Effect of Body Mass Index and Waist Circumference in Predicting Nonalcoholic Fatty Liver Disease.
Lee HL; Baik SJ; Cho WJ; Son DH; Lee YJ
Metab Syndr Relat Disord; 2023 Nov; 21(9):497-502. PubMed ID: 37669452
[No Abstract] [Full Text] [Related]
31. Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women: The Women's Health Initiative.
Cordola Hsu AR; Xie B; Peterson DV; LaMonte MJ; Garcia L; Eaton CB; Going SB; Phillips LS; Manson JE; Anton-Culver H; Wong ND;
Circ Heart Fail; 2021 Apr; 14(4):e007297. PubMed ID: 33775111
[TBL] [Abstract][Full Text] [Related]
32. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
[TBL] [Abstract][Full Text] [Related]
33. Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study.
Yun KE; Nam GE; Lim J; Park HS; Chang Y; Jung HS; Kim CW; Ko BJ; Chung EC; Shin H; Ryu S
PLoS One; 2016; 11(7):e0158710. PubMed ID: 27420035
[TBL] [Abstract][Full Text] [Related]
34. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
[TBL] [Abstract][Full Text] [Related]
35. Adherence to the DASH, MeDi, and MIND diet scores and the incidence of metabolically unhealthy phenotypes.
Golzarand M; Moslehi N; Mirmiran P; Azizi F
Obes Res Clin Pract; 2023; 17(3):226-232. PubMed ID: 37037714
[TBL] [Abstract][Full Text] [Related]
36. Metabolically healthy obesity was significantly associated with increased risk of gallstones.
Man S; Gao Y; Lv J; Tong M; Yin J; Wang B; Ning Y; Li L
Eur J Endocrinol; 2022 Jan; 186(2):275-283. PubMed ID: 34889778
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Obesity Phenotypes and Risk of Lung Cancer: A Prospective Cohort Study of 450,482 UK Biobank Participants.
Shao F; Chen Y; Xu H; Chen X; Zhou J; Wu Y; Tang Y; Wang Z; Zhang R; Lange T; Ma H; Hu Z; Shen H; Christiani DC; Chen F; Zhao Y; You D
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014876
[TBL] [Abstract][Full Text] [Related]
38. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling.
Cao T; Tong C; Li Q; Han Y; Halengbieke A; Ni X; Gao B; Zheng D; Yang X
Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1245-1256. PubMed ID: 38342721
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
[TBL] [Abstract][Full Text] [Related]
40. The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
Kouvari M; Chrysohoou C; Skoumas J; Pitsavos C; Panagiotakos DB; Mantzoros CS;
Metabolism; 2022 Mar; 128():154893. PubMed ID: 34600906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
